Delays in providing first medical contact to device time for STEMI can result in worse patient outcomes, highlighting the ...

Researchers from the Germans Trias i Pujol research institute (IGTP) have conducted a preclinical study on the effects of the ...

Patients with AAV are associated with an increased risk for MI, particularly during the first 3 months after diagnosis.

CARDIOVASCULAR diseases (CVDs) continue to be the leading cause of death in the Philippines, with access to timely and ...

People following an unhealthy plant-based diet had a 65% greater chance of elevated levels of a key heart attack biomarker, ...

Patients with atrial fibrillation now live longer after stroke, heart failure, or myocardial infarction, but bleeding risks ...

A new study published in the Journal of American Medical Association showed that switching from ticagrelor to clopidogrel one month after percutaneous coronary intervention (PCI) for ...

A woman filed a lawsuit saying her husband died after doctors allegedly ignored his abnormal heart readings before his ...

The following is a summary of “Endocrine response in cardiogenic shock complicating myocardial infarction: the prognostic value of growth hormone and IGF-1,” published in the May 2025 issue of Journal ...

A new study published in the European Heart Journal showed that patients with myocardial infarction (MI) and preserved left ...

Eli Lilly (LLY) will acquire Verve Therapeutics (VERV) for up to $13.5/share, aiming to revolutionize cholesterol treatment.

Background: Major noncardiac surgery carries high rates of postoperative myocardial injury and other complications. Remote ischemic preconditioning (RIPC) was reported to decrease these complications.